Terbutaline (Brethine, Brethaire, Bricanyl)

Category:

  • Respiratory

Description:

  • Antiasthmatic, bronchodilator, tocolytic

Indications:

  • Bronchospasm (asthma, COPD)

  • Premature labor (not FDA approved indication)

Precautions:

  • Pregnancy category B; compatible with breast feeding

  • Cardiac disorders, hyperthyroidism, diabetes mellitus, prostatic hypertrophy

  • Elderly, hypertensive, glaucoma

Adverse Reactions (Side Effects):

  • CNS: anxiety, dizziness, headache, insomnia, nervousness, shakiness, tremor

  • CV: angina, cardiac arrest, dysrhythmias, hypertension, palpitations, tachycardia

  • GI: elevated liver enzymes, nausea, vomiting

Dosage:

Administered via inhalation, subcutaneously, intravenously, and orally

  • Adult: 

    • Bronchospasm: 

      • INH 2 puffs separated by 1 minute every 4-6 hours

      • PO 2.5-5mg every 8 hours to max 15mg daily

      • SC 0.25mg, may repeat once in 15-30 minutes

    • Premature labor: 

      • SC 0.25mg every hour

      • IV INF 0.01 mg/min, titrate upward to max of 0.08 mg/min; maintain at minimum effective dose for 4 hours

      • PO 5mg every 4 hours for 48 hours, then 5mg every 6 hours as maintenance for above doses

  • Child:   

    • INH 1-2 puffs every 4-6 hours

    • PO 0.05 mg/kg/dose every 8 hours, increased gradually to 0.15 mg/kg/dose to max daily dose 5mg (<12 years)

    • SC 0.005-0.01 mg/kg/dose to max 0.4 mg/kg/dose every 15-20 minutes for 2 doses

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site